Sentence examples for completion shown from inspiring English sources

More importantly, the lack of completion shown here isn't anything to worry about, since the game has only been in development for a short time.

SDS-PAGE analysis on the third day showed that the deglycosylation reaction was near completion shown in Figure 1.

The difference in self and proxy-report completion shown in table 1, resulted from parents (N = 429) who gave consent for their child to complete PedsQL™, but did not complete a questionnaire themselves.

Perhaps they do, but with a remodelled offensive line doing a sensational job of protecting Flacco and the quarterback – who averaged 18.3 yards per completion – showing what he can do when given the time, they also just have a better team than most had given them credit for.

Open image in new window Fig. 1 Schematic intelligent well completion, showing packers, inflow control valves, hydraulic and electric control lines.

Fig. 13 shows photos of reference flats being used to check two test flats at different stages of completion, showing the different patterns of interference fringes.

Evidence on the efficacy of interventions to improve treatment adherence and completion showed that shorter treatment duration was significantly associated with increased adherence [ 39– 41].

Rates of study completion showed an increasing trend across cohorts: 5/9 (56%) in cohort 1, 6/8 (75%) in cohort 2 and 20/23 877%) in cohort 3.

Treatment completion showed a similar pattern, ranging from 59%to78%8% in the self-treatment groups, and direct observation did not improve this (RR 1.07, 95% CI 0.96 to 1.19; six trials, 1839 participants, moderate quality evidence).

Median PFS was 1.7 months and PFS-6 in the population treated was 22.5%; moreover, patients that initiated fotemustine at least 3 months after temozolomide completion showed a significantly higher PFS-6 (30.7 versus 16.7%) than patients who initiated fotemustine immediately after temozolomide completion (P = 0.034).

Analysis on completion showed no significant differences in any end point or in any individual composite end point, although the alogliptin cohort showed nonsignificant sub-unitary hazard ratios (favoring the addition of alogliptin) in four out of five of the CV event types included in the analysis.